Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Zirconium-89

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Monopar Announces Positive Data On MNPR-101-Zr Tumor Targeting
    Monopar Announces Positive Data On MNPR-101-Zr Tumor Targeting

    12 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/12/2945115/0/en/Monopar-Announces-Positive-Early-Human-Clinical-Data-Validating-the-Tumor-Targeting-Ability-of-MNPR-101-Zr.html

    GLOBENEWSWIRE
    12 Sep 2024
    Share Share
    FDA to re-review application for AstraZeneca’s hyperkalaemia treatment
    FDA to re-review application for AstraZeneca’s hyperkalaemia treatment

    19 Oct 2016

    // Niamh Marriott EU PHARMACEUTICAL

    http://www.europeanpharmaceuticalreview.com/44686/news/industry-news/fda-astrazeneca-hyperkalaemia/

    Niamh Marriott EU PHARMACEUTICAL
    19 Oct 2016
    Share Share